Objective: Opioid prescribing for chronic pain significantly contributes to opioid overdose deaths in the United States. Naloxone as a take-home antidote to opioid overdose is underutilized and has not been evaluated in the high-risk chronic pain population. The objective was to increase overdose education and naloxone distribution (OEND) to high-risk patients on long-term opioid therapy for pain by utilizing group visits in primary care.
Design: Quality improvement intervention among two primary care clinics.
Setting: A large, academic facility within the Veterans Health Administration.
Subjects: Patients prescribed ≥100 mg morphine-equivalent daily dose or coprescribed opioids and benzodiazepines.
Methods: One clinic provided usual care with respect to OEND; another clinic encouraged attendance at an OEND group visit to all of its high-risk patients.
Results: We used attendance at group visits, prescriptions of naloxone issued, and patient satisfaction scores to evaluate this format of OEND.
Key results: Group OEND visits resulted in significantly more naloxone prescriptions than usual care. At these group visits, patients were engaged, valued the experience, and all requested a prescription for the naloxone kit.
Conclusion: This quality improvement pilot study suggests that OEND group visits are a promising model of care.
Keywords: Chronic Pain; Harm Reduction; Naloxone; Patient Safety; Quality Improvement.
2017 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.